Viblin Healthcare Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 16-11-2024
- Paid Up Capital ₹ 3.00 M
as on 16-11-2024
- Company Age 6 Year, 12 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.14 Cr
as on 16-11-2024
- Revenue 303.07%
(FY 2023)
- Profit 141.22%
(FY 2023)
- Ebitda 146.12%
(FY 2023)
- Net Worth 11.12%
(FY 2023)
- Total Assets 67.85%
(FY 2023)
About Viblin Healthcare
The Corporate was formerly known as Shreedhatri Herbals Private Limited. The Company is engaged in the Consumer Goods Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹1.14 Cr.
Varsha Jain and Vipin Jain serve as directors at the Company.
- CIN/LLPIN
U74110DL2018PTC343378
- Company No.
343378
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Dec 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Viblin Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Varsha Jain  | Director | 20-Dec-2018 | Current |
| Vipin Jain | Additional Director | 18-Jun-2020 | Current |
Financial Performance of Viblin Healthcare.
Viblin Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 303.07% increase. The company also saw a substantial improvement in profitability, with a 141.22% increase in profit. The company's net worth Soared by an impressive increase of 11.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Viblin Healthcare?
In 2023, Viblin Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Parna Rural Agri Private LimitedActive 8 years 4 monthsVarsha Jain and Vipin Jain are mutual person
- Jeeshree Organic Agro Private LimitedActive 1 year 10 months
Varsha Jain and Vipin Jain are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 14 May 2023 | ₹9.00 M | Open |
Axis Bank Limited Creation Date: 20 Jun 2022 | ₹2.40 M | Open |
How Many Employees Work at Viblin Healthcare?
Unlock and access historical data on people associated with Viblin Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Viblin Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Viblin Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
